We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+25.02%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$336M
AUM Growth
+$9.25M
Cap. Flow
-$40.5M
Cap. Flow %
-12.03%
Top 10 Hldgs %
39.7%
Holding
90
New
18
Increased
16
Reduced
19
Closed
33

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$9.77M
2
ELV icon
Elevance Health
ELV
+$8.59M
3
BDX icon
Becton Dickinson
BDX
+$7.65M
4
LLY icon
Eli Lilly
LLY
+$7.47M
5
ABBV icon
AbbVie
ABBV
+$6.73M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$10.8M
2
MRK icon
Merck
MRK
+$8.29M
3
ZBH icon
Zimmer Biomet
ZBH
+$6.81M
4
DNLI icon
Denali Therapeutics
DNLI
+$6.5M
5
SNY icon
Sanofi
SNY
+$6.27M

Sector Composition

Rank Sector Weight
1 Healthcare 91.04%
2 Energy 4.31%
3 Financials 0.52%
4 Consumer Discretionary 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$626B
$5.51M 1.64%
+35,000
New +$5.16M
DNLI icon
27
Denali Therapeutics
DNLI
$3.95B
$4.82M 1.43%
57,500
-107,500
-65% -$6.5M
GH icon
28
Guardant Health
GH
$22.2B
$4.51M 1.34%
35,000
+5,000
+17% +$575K
NTRA icon
29
Natera
NTRA
$45.1B
$4.48M 1.33%
45,000
-21,000
-32% -$1.75M
MDT icon
30
Medtronic
MDT
$116B
$4.1M 1.22%
+35,000
New +$3.85M
ZLAB icon
31
Zai Lab
ZLAB
$2.92B
$4.06M 1.21%
30,000
+5,000
+20% +$509K
ARWR icon
32
Arrowhead Research
ARWR
$12.6B
$3.84M 1.14%
+50,000
New +$3.2M
SWAV
33
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$3.63M 1.08%
35,000
+10,000
+40% +$866K
PNTG icon
34
Pennant Group
PNTG
$1.33B
$3.48M 1.04%
60,000
-15,000
-20% -$721K
HCA icon
35
HCA Healthcare
HCA
$89.1B
$3.29M 0.98%
+20,000
New +$2.92M
NTLA icon
36
Intellia Therapeutics
NTLA
$1.68B
$3.26M 0.97%
+60,000
New +$2.18M
GMED icon
37
Globus Medical
GMED
$11.4B
$3.26M 0.97%
50,000
-15,000
-23% -$862K
AGIO icon
38
Agios Pharmaceuticals
AGIO
$1.95B
$3.25M 0.97%
75,000
-45,000
-38% -$1.78M
KURA icon
39
Kura Oncology
KURA
$882M
$3.1M 0.92%
95,000
+45,000
+90% +$1.58M
AERI
40
DELISTED
Aerie Pharmaceuticals
AERI
$2.7M 0.8%
+200,000
New +$2.42M
ALEC icon
41
Alector
ALEC
$233M
$2.5M 0.74%
165,000
+135,000
+450% +$1.68M
BIIB icon
42
Biogen
BIIB
$30.1B
$2.45M 0.73%
+10,000
New +$2.58M
KNSA icon
43
Kiniksa Pharmaceuticals
KNSA
$6.07B
$2.38M 0.71%
135,000
+15,000
+13% +$263K
AKRO
44
DELISTED
Akero Therapeutics
AKRO
$2.19M 0.65%
85,000
– –
MGNX icon
45
MacroGenics
MGNX
$249M
$2.06M 0.61%
90,000
– –
ALNY icon
46
Alnylam Pharmaceuticals
ALNY
$29.6B
$1.95M 0.58%
15,000
-10,000
-40% -$1.34M
PTCT icon
47
PTC Therapeutics
PTCT
$6.15B
$1.84M 0.55%
30,100
– –
REPL icon
48
Replimune Group
REPL
$1.15B
$1.81M 0.54%
+47,500
New +$1.98M
EHTH icon
49
eHealth
EHTH
$39.1M
$1.76M 0.53%
25,000
-45,000
-64% -$3.42M
PGNY icon
50
Progyny
PGNY
$2.04B
$1.7M 0.5%
+40,000
New +$1.3M
1
2
3 4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Integral Health Asset Management held 90 positions worth $336M, up 2.8% from $327M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Integral Health Asset Management withdrew a net $40.5M in Q4 2020, closing 33 positions and reducing 19 holdings. Its most notable exit was Humana, an estimated $10.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 85% a quarter earlier, followed by Energy and Financials.

Against the trend, Integral Health Asset Management opened a new position in Elevance Health worth $8.99M.

  • Integral Health Asset Management's largest Q4 2020 buy was Elevance Health: 28,000 shares worth $8.99M.
  • Integral Health Asset Management added most to Acadia Healthcare in Q4 2020, an estimated $9.77M increase.
  • Integral Health Asset Management's biggest Q4 2020 reduction was Denali Therapeutics, cutting an estimated $6.5M.
  • Integral Health Asset Management fully exited Humana in Q4 2020, selling an estimated $10.8M.
  • Integral Health Asset Management's ten largest holdings make up 40% of its $336M portfolio in Q4 2020.
  • Integral Health Asset Management opened 18 new positions and closed 33 in Q4 2020.
  • Integral Health Asset Management's portfolio value rose 2.8% quarter-over-quarter to $336M.

Based on Integral Health Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.